NanoInk, Inc. Appoints Three New Business Development and Sales Executives |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
NanoInk, Inc.
1335 Randolph Street
Chicago, IL, 60607
USA
Press release date: April 10, 2006
SKOKIE, Illinois, April 10, 2006 - NanoInk, Inc., a world-leader in the emerging field of nanometer-scale manufacturing and applications development, today announced the appointment of three senior executives with extensive experience in sales and marketing to the pharmaceutical, technology, and semiconductor industries.
Jim Whittle has been named Vice President, Business Development and joins NanoInk from AT Kearney, where he was a member of the Global Healthcare/Lifesciences sector team.
Mr. Whittle's previous experience includes management and marketing positions at Russell Reynolds Associates, Meiji-McVite's Japan, Keebler, Warner Lambert (now part of Pfizer), and Beecham Products (now part of Bristol Meyers Squibb). He is a distinguished graduate of the J. L. Kellogg School of Management, Northwestern University, where he received his MBA with honors. He also holds a Bachelor of Science with honors from Brigham Young University.
Bruce Dudzik has been named Senior Director, Business Development for NanoInk. He will focus his efforts on developing partnerships that utilize NanoInk's proprietary DPNŽ technology in the biotech and lifescience sectors, as well as working to expand the Company's Nanoencryption(TM) business.
Mr. Dudzik joins NanoInk from Affymetrix and brings over 25 years of experience in research, marketing and business development in the microarray and bioscience industry. He has served at senior levels of business development at Affymetrix, and has held leadership business development positions at Amersham, Vysis, and Amoco Biotechnology Division. His biotech experience is particularly well-suited for the future business goals of NanoInk. Mr. Dudzik received his MBA from DePaul University and his BS in Biology from the University of Illinois at Urbana-Champaign.
Tom Levesque has been named Senior Director, DPNŽ Global Sales. He will lead NanoInk's sales and marketing efforts worldwide of the Company's proprietary product, the Nscriptor(TM).
Mr. Levesque joins NanoInk from SYNOVA and has over 25 years of experience in sales and marketing capital equipment to the technology industry. He has also worked in senior sales positions at Ascend Instruments, FOSS NIRSystems, WYKO, Kulicke & Soffa Industries, and Fisons Instruments. He is a graduate of Northeastern University in Boston, MA, where he earned Bachelors and Masters of Science degrees.
"I am very pleased that Jim, Bruce, and Tom have joined NanoInk," said Cedric Loiret-Bernal, M.D., NanoInk President and Chief Executive Officer. "NanoInk will benefit greatly from these seasoned executives with proven leadership skills and their team-oriented spirit. They possess execution skills that are key to the implementation of our strategic vision as the Company pursues commercial profitability."
NanoInk is focused on providing solutions for problems in the pharmaceutical and semiconductor sectors. With over $25 billion of revenues being lost annually to counterfeit products, pharmaceutical companies are looking for ways to identify fraudulent products that not only hurt sales of patented and licensed drugs but are a global safety threat to consumers. With computer chip nodes going down to 65nn, the photomask repair industry requires repair capabilities that can only be offered by new technology such as DPNŽ.
About NanoInk
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the lifescience and semiconductor industries. With DPNŽ, a patented and proprietary nanofabrication technology that allows for unmatched flexibility, accuracy and also its high-resolution Nanoencryption(TM) technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair, and nanoscale rapid prototyping. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 100 patent and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., see www.nanoink.net.
CONTACT:Dileep R. Gangolli Investor Relations and Financial Communications NanoInk, Inc. (847) 745-3635 ir@nanoink.net
|
|
|
|
|
|
|
|
|
|
|
| 
